Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:17 PM
Ignite Modification Date:
2026-03-26 @ 3:17 PM
NCT ID:
NCT07339956
Eligibility Criteria:
Inclusion Criteria:
* Oral therapy with at least one antiplatelet or anticoagulant agent, including: aspirin, clopidogrel, ticagrelor, prasugrel, warfarin, rivaroxaban, apixaban, edoxaban, dabigatran, etc.;
* BARC stage 1 or 2;
* Traditional Chinese Medicine pattern identified as phlegm-heat and blood stasis obstruction syndrome;
* Age 18-90 years;
* Signed informed consent.
Exclusion Criteria:
* Patients with gastrointestinal bleeding resulting in hemoglobin levels \<20 g/L and/or requiring hospitalization;
* Gastrointestinal malignancies;
* Cases where the source of occult blood cannot be distinguished, such as fresh bleeding from hemorrhoids;
* Concurrent use of hemostatic traditional Chinese medicine preparations like Yunnan Baiyao;
* Significant liver or kidney dysfunction, with ALT, AST, or serum creatinine exceeding three times the upper limit of normal;
* Pregnant women, women planning pregnancy, or lactating women;
* Individuals deemed unsuitable for this clinical trial by the investigator.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
90 Years
Study:
NCT07339956
Study Brief:
Protocol Section:
NCT07339956